Therapeutic potential of trazodone in trigeminal neuralgia based on inflammation and oxidative stress: an in vitro experimental study
Journal of Oral & Facial Pain and Headache · 2024
DOI: 10.22514/jofph.2024.020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oral & Facial Pain and Headache, 2024. Verfasst von Jun Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), 31…. Hauptthemen laut MEDLINE: Trazodone, Oxidative Stress, Trigeminal Neuralgia, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Trigeminal neuralgia (TN) is a debilitating condition affecting the patients’ life quality. New therapeutic approaches and novel drugs are required to treat TN. Trazodone being a serotonin antagonist and reuptake inhibitor (SARI) provides neuroprotection, however its role and underlying mechanism in TN in vitro or in vivo are not clear. This study was aimed to investigate the trazodone impact on glial BV-2 cells regarding TN. It was found that trazodone inhibited the BV-2 cells growth and suppressed the inflammation and oxidative stress in Lipopolysaccharide (LPS)-treated BV-2 cells. Trazodone treatment specifically decreased the levels of Tumor Necrosis Factor-alpha (TNF-α), Interleukin-6 (IL-6), Interleukin-1 beta (IL-1β) (p < 0.05), and Reactive Oxygen Species (ROS) (p < 0.01). Moreover, trazodone suppressed the Mitogen-Activated Protein Kinase (MAPK) pathway in LPS-treated BV-2 cells. These outcomes demonstrate that trazodone suppressed glial cell hyperproliferation, inflammation, and oxidative stress through MAPK pathway activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), 310003 Hangzhou, Zhejiang, China.
- Department of Geriatrics, Tongji Hospital, School of Medicine Tongji University, 200065 Shanghai, China.
Zitieren
APA
Yang, J., Huang, J., Pan, Z., & Wang, X. (2024). Therapeutic potential of trazodone in trigeminal neuralgia based on inflammation and oxidative stress: an in vitro experimental study. Journal of Oral & Facial Pain and Headache. https://doi.org/10.22514/jofph.2024.020
Vancouver
Yang J, Huang J, Pan Z, Wang X. Therapeutic potential of trazodone in trigeminal neuralgia based on inflammation and oxidative stress: an in vitro experimental study. Journal of Oral & Facial Pain and Headache. 2024. doi:10.22514/jofph.2024.020
BibTeX
@article{Yang2024,
author = {Yang, Jun and Huang, Junling and Pan, Zhimin and Wang, Xiao},
title = {Therapeutic potential of trazodone in trigeminal neuralgia based on inflammation and oxidative stress: an in vitro experimental study},
journal = {Journal of Oral & Facial Pain and Headache},
year = {2024},
doi = {10.22514/jofph.2024.020}
}
EUVIMED